Abstract
Insulin release from pancreatic islet β-cells is stimulated by glucose. Glucose-induced insulin release is potentiated or suppressed by hormones and neural substances. Ghrelin, a novel acylated 28-amino acid peptide isolated from stomach, is the endogenous ligand for the growth hormone (GH) secretagogue-receptor (GHS-R). Circulating ghrelin is produced predominantly in stomach. Ghrelin is a potent stimulator of GH release and feeding as well as exhibiting positive cardiovascular effects. In relation to the glucose metabolism, initial studies indicated that low plasma ghrelin levels are associated with elevated fasting insulin levels, insulin resistance, and obesity. It has recently been demonstrated that ghrelin suppresses glucose-induced insulin release via Gαi2 subtype of GTP-binding proteins and delayed outward K+ (Kv) channels, representing a novel signaling mechanism, and that the ghrelin originating from islets regulates insulin release and thereby glycemia. Furthermore, elimination of ghrelin enhances insulin release to prevent or ameliorate glucose intolerance in high-fat diet fed mice and ob/ob mice. This review focuses on the physiological roles of ghrelin in regulating insulin release and glycemia, the insulinostatic mechanisms of ghrelin in islet β-cells, and the potential of ghrelin-GHS-R system as the therapeutic target to treat type 2 diabetes.
Keywords: Ghrelin, GHS-R, Insulin release, Islet β-cell, Kv channel, Diabetes, Ghrelin-knockout
Current Diabetes Reviews
Title: Ghrelin Regulates Insulin Release and Glycemia: Physiological Role and Therapeutic Potential
Volume: 4 Issue: 1
Author(s): Toshihiko Yada, Katsuya Dezaki, Hideyuki Sone, Masaru Koizumi, Boldbaatar Damdindorj, Masanori Nakata and Masafumi Kakei
Affiliation:
Keywords: Ghrelin, GHS-R, Insulin release, Islet β-cell, Kv channel, Diabetes, Ghrelin-knockout
Abstract: Insulin release from pancreatic islet β-cells is stimulated by glucose. Glucose-induced insulin release is potentiated or suppressed by hormones and neural substances. Ghrelin, a novel acylated 28-amino acid peptide isolated from stomach, is the endogenous ligand for the growth hormone (GH) secretagogue-receptor (GHS-R). Circulating ghrelin is produced predominantly in stomach. Ghrelin is a potent stimulator of GH release and feeding as well as exhibiting positive cardiovascular effects. In relation to the glucose metabolism, initial studies indicated that low plasma ghrelin levels are associated with elevated fasting insulin levels, insulin resistance, and obesity. It has recently been demonstrated that ghrelin suppresses glucose-induced insulin release via Gαi2 subtype of GTP-binding proteins and delayed outward K+ (Kv) channels, representing a novel signaling mechanism, and that the ghrelin originating from islets regulates insulin release and thereby glycemia. Furthermore, elimination of ghrelin enhances insulin release to prevent or ameliorate glucose intolerance in high-fat diet fed mice and ob/ob mice. This review focuses on the physiological roles of ghrelin in regulating insulin release and glycemia, the insulinostatic mechanisms of ghrelin in islet β-cells, and the potential of ghrelin-GHS-R system as the therapeutic target to treat type 2 diabetes.
Export Options
About this article
Cite this article as:
Yada Toshihiko, Dezaki Katsuya, Sone Hideyuki, Koizumi Masaru, Damdindorj Boldbaatar, Nakata Masanori and Kakei Masafumi, Ghrelin Regulates Insulin Release and Glycemia: Physiological Role and Therapeutic Potential, Current Diabetes Reviews 2008; 4 (1) . https://dx.doi.org/10.2174/157339908783502352
DOI https://dx.doi.org/10.2174/157339908783502352 |
Print ISSN 1573-3998 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6417 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Regulation of Adrenomedullin and its Family Peptide by RAMP System – Lessons from Genetically Engineered Mice
Current Protein & Peptide Science Endocannabinoid Metabolic Pathways and Enzymes
Current Drug Targets - CNS & Neurological Disorders Hyperandrogenism, Insulin Resistance and Hyperinsulinemia as Cardiovascular Risk Factors in Diabetes Mellitus
Current Diabetes Reviews Ascorbic acid-Catalyzed One-Pot Three-Component Biginelli Reaction: A Practical and Green Approach towards Synthesis of 3,4-dihydropyrimidin- 2(1H)-ones/thiones
Letters in Organic Chemistry The Heat Stress Response and Diabetes: More Room for Mitochondrial Implication
Current Pharmaceutical Design Reconsideration of Japanese Traditional Herbal Medicine: New Field of Research and Clinical Medicine
Mini-Reviews in Medicinal Chemistry Infection, Infectious Agents and Vascular Disease
Reviews on Recent Clinical Trials Type 3 Diabetes Mellitus: A Novel Implication of Alzheimers Disease
Current Topics in Medicinal Chemistry The Use of Net Analyte Signal Aspect in Univariate Calibration for Simultaneous Determination of Guaifenesin, Pseudoephedrine and Chlorpheniramine in Cough Syrup Formulations
Current Pharmaceutical Analysis Proteins Structures in Leishmania Amastigotes for Clinical Remission of Psoriasis
Current Proteomics Biomarkers for Systemic Therapy in Ovarian Cancer
Current Cancer Drug Targets Clinical Profile of Relaxin, a Possible New Drug for Human Use
Current Drug Safety Multi-Aspect Candidates for Repositioning: Data Fusion Methods Using Heterogeneous Information Sources
Current Medicinal Chemistry Meet Our Editor:
Current Hypertension Reviews Roles of IL-6-gp130 Signaling in Vascular Inflammation
Current Cardiology Reviews Antidiabetic Agents in Patients with Chronic Kidney Disease and End-Stage Renal Disease on Dialysis: Metabolism and Clinical Practice
Current Drug Metabolism Towards Drug Discovery for Brain Tumours: Interaction of Kinins and Tumours at the Blood Brain Barrier Interface
Recent Patents on CNS Drug Discovery (Discontinued) Targeting Hypertension: Superoxide Anions are Involved in Apelin-induced Long-term High Blood Pressure and Sympathetic Activity in the Paraventricular Nucleus
Current Neurovascular Research Mechanical Circulatory Support for End-Stage Heart Failure in Repaired and Palliated Congenital Heart Disease
Current Cardiology Reviews Medication-Induced Acute Abdominal Pain: Evaluation with CT Imaging
Current Medical Imaging